Document Detail


Neck dissection after chemoradiotherapy: timing and complications.
MedLine Citation:
PMID:  21079159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To determine the incidence of postchemoradiotherapy (post-CRT) neck dissection (ND) complications; to ascertain whether timing (< 12 vs ≥ 12 weeks) from CRT to ND or other factors are associated with increased complications; and to determine whether ND timing influences disease control or survival.
DESIGN: Ten-year retrospective analysis.
SETTING: Tertiary care center.
PATIENTS: One hundred five patients with head and neck cancer undergoing ND after CRT.
MAIN OUTCOME MEASURES: Complications and survival variables compared between groups undergoing ND less than 12 weeks (less-than-12-weeks ND group) and 12 weeks or more (12-weeks-or-more ND group) after CRT.
RESULTS: Sixty-seven NDs were performed less than 12 weeks and 38 were performed 12 weeks or more after CRT. Patient characteristics, treatment, and ND pathology results were comparable between the 2 ND groups. The incidence of complications between the less-than-12-weeks and the 12-weeks-or-more ND groups included major wound complications in 8 of 67 (11.9%) vs 1 of 38 (2.6%; P = .15), minor wound complications in 11 of 67 (16.4%) vs 4 of 38 (10.5%; P = .56), airway complications in 7 of 67 (10.4%) vs 2 of 38 (5.3%; P = .48), and systemic complications in 9 of 67 (13.4%) vs 2 of 38 (5.3%; P = .32). The number of patients with at least 1 complication was significantly smaller in the 12-weeks-or-more ND group (P = .04). Multivariate analysis showed that radical ND was significantly associated with an increased number of complications, and higher radiation doses approached significance (P = .05). Induction chemotherapy was associated with fewer wound complications (P = .01). There were no significant differences in overall survival (P = .82), progression-free survival (P = .77), or regional relapse (P = .54) between groups. Positive ND findings were associated with diminished progression-free and overall survival.
CONCLUSION: These findings indicate that ND can be safely performed 12 weeks or more after CRT without adversely affecting surgical complications or survival variables.
Authors:
Laura A Goguen; Claudia I Chapuy; Yi Li; Sihai D Zhao; Donald J Annino
Related Documents :
20931429 - Short-term outcomes after surgery for colorectal cancer in turkish patients aged 70 and...
8416329 - Early ambulation following diagnostic 7-french cardiac catheterization: a prospective r...
3871259 - Mediastinal infection after open heart surgery.
12844089 - Cardiac risk stratification in patients undergoing endoluminal graft repair of abdomina...
2357139 - Cardiac surgery in patients age 80 years or older.
21106309 - Do elderly patients experience increased perioperative or postoperative morbidity or mo...
17666169 - Outcome after distal metatarsal osteotomy for hallux valgus: a prospective randomized c...
6785059 - Aciclovir and trifluorothymidine in herpetic keratitis. preliminary report of a multice...
21847709 - Efficacy of lower-extremity venous thrombolysis in the setting of congenital absence or...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of otolaryngology--head & neck surgery     Volume:  136     ISSN:  1538-361X     ISO Abbreviation:  Arch. Otolaryngol. Head Neck Surg.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-16     Completed Date:  2010-12-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8603209     Medline TA:  Arch Otolaryngol Head Neck Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1071-7     Citation Subset:  AIM; IM    
Affiliation:
Division of Otolaryngology, Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA. lgoguen@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Carcinoma, Squamous Cell / drug therapy,  pathology,  radiotherapy,  surgery*
Combined Modality Therapy
Female
Head and Neck Neoplasms / drug therapy,  pathology,  radiotherapy,  surgery*
Humans
Lymphatic Metastasis
Male
Middle Aged
Neck Dissection / methods*
Postoperative Complications
Proportional Hazards Models
Regression Analysis
Retrospective Studies
Survival Rate
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hearing loss and complaint in patients with head and neck cancer treated with radiotherapy.
Next Document:  Transoral robotic surgery for advanced oropharyngeal carcinoma.